肺動脈性肺高血圧症（PAH）とは、心臓の右側と肺に血液を供給する動脈に起こる高血圧の一種です。症状は、胸痛、倦怠感、突然の失神、足のむくみ（浮腫）などです。危険因子としては、家族歴、年齢、肥満、閉塞性睡眠時無呼吸症候群、先天性心疾患、肺疾患、肝疾患、強皮症やループスなどの結合組織疾患などの疾患が挙げられます。治療には、シルデナフィル、プロスタノイド、カルシウムチャネル遮断薬などがあります。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Pulmonary Arterial Hypertension - Overview
Pulmonary Arterial Hypertension - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Pulmonary Arterial Hypertension - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Pulmonary Arterial Hypertension - Companies Involved in Therapeutics Development
Pulmonary Arterial Hypertension - Drug Profiles
Pulmonary Arterial Hypertension - Dormant Projects
Pulmonary Arterial Hypertension - Discontinued Products
Pulmonary Arterial Hypertension - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Pulmonary Arterial Hypertension, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Target, 2022 (Contd..2)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Pulmonary Arterial Hypertension - Dormant Projects, 2022
Pulmonary Arterial Hypertension - Dormant Projects, 2022 (Contd..1)
Pulmonary Arterial Hypertension - Dormant Projects, 2022 (Contd..2)
Pulmonary Arterial Hypertension - Dormant Projects, 2022 (Contd..3)
Pulmonary Arterial Hypertension - Dormant Projects, 2022 (Contd..4)
Pulmonary Arterial Hypertension - Discontinued Products, 2022
List of Figures
Number of Products under Development for Pulmonary Arterial Hypertension, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
